The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Stalevo is indicated for the treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase DDC inhibitor treatment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
